Long-acting (basal) insulin on every 2026 Hawaii Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 8 stand-alone Part D plans in Hawaii cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | AARP Medicare Rx Saver from UHC$0.00/moS5921-381 | Humana Basic Rx Plan$0.40/moS5884-115 | SilverScript Choice$14.70/moS5601-066 | Wellcare Value Script$21.60/moS4802-164 | Wellcare Classic$21.70/moS4802-095 | Humana Value Rx Plan$51.60/moS5884-212 | Humana Premier Rx Plan$90.20/moS5884-179 | AARP Medicare Rx Preferred from UHC$139.20/moS5921-414 |
|---|---|---|---|---|---|---|---|---|
| Lantusinsulin glargine | Tier 316% | Tier 323% | Tier 319% | Tier 325% | Tier 325% | Tier 320% | Tier 3$45.00 | Tier 317% |
| insulin glargineunbranded Lantus | Tier 316% | Not covered | Not covered | Tier 325% | Tier 325% | Not covered | Not covered | Tier 317% |
| Basaglarinsulin glargine | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Semgleeinsulin glargine-yfgn | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Rezvoglarinsulin glargine-aglr | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Toujeoinsulin glargine, U-300 | Tier 316% | Tier 323% | Tier 319% | Not covered | Not covered | Tier 320% | Tier 3$45.00 | Tier 317% |
| Tresibainsulin degludec | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 3$45.00 | Not covered |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.